En Carta Diagnostics raises $5.3M (France, Jul 2026)
$5.3M
€5MReach the investors backing rounds like this
Backed by Blue Forest Ventures, Ring Capital +3 more · verified emails and LinkedIn on Datapile
Generated social card
Headline
En Carta Diagnostics secures 5 million euros for home testi - n24.com.tr
About
En Carta Diagnostics is a Paris-based deeptech startup focused on developing home-based molecular diagnostic tools for Lyme disease and sexually transmitted infections. The company aims to provide results within 30 minutes, matching the precision of laboratory PCR tests, and has recently achieved FDA Breakthrough Device Designation.
Article summary
En Carta Diagnostics secures 5 million euros for home testi n24.com.tr
Founder
Guillaume Horreard
Co-founder
Investors · 5
3 hiddenRelated rounds
| Aug 04, 2026 | Shiplog | $858K | — | France |
| Jul 27, 2026 | ENGO Eyewear | $5.5M | — | France |
| Jul 22, 2026 | Brenus Pharma | $12.6M | Series A | France |
| Jul 22, 2026 | Mistral AI | $1.14B | — | France |